Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « March » « 2025 » M T W T F S S 24 25 26 27 28 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 6   - « March » « 2025 » M T W T F S S 24 25 26 27 28 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 6   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
LY3541860 / Eli Lilly
NCT06220669: A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis	Recruiting	2	200	Europe, US, RoW	LY3541860, Placebo	Eli Lilly and Company	Multiple Sclerosis	08/27	08/28
NCT06859294: A Study of LY3541860 in Adult Participants With Moderately to Severely Active Rheumatoid Arthritis	Not yet recruiting	2	40	US	LY3541860	Eli Lilly and Company	Rheumatoid Arthritis	02/26	09/26
NCT05042310: A Study of LY3541860 in Healthy Japanese and Non-Japanese Participants	Completed	1	94	Japan	LY3541860, Placebo	Eli Lilly and Company	Healthy	12/23	12/23

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
LY3541860 / Eli Lilly
NCT06220669: A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis	Recruiting	2	200	Europe, US, RoW	LY3541860, Placebo	Eli Lilly and Company	Multiple Sclerosis	08/27	08/28
NCT06859294: A Study of LY3541860 in Adult Participants With Moderately to Severely Active Rheumatoid Arthritis	Not yet recruiting	2	40	US	LY3541860	Eli Lilly and Company	Rheumatoid Arthritis	02/26	09/26
NCT05042310: A Study of LY3541860 in Healthy Japanese and Non-Japanese Participants	Completed	1	94	Japan	LY3541860, Placebo	Eli Lilly and Company	Healthy	12/23	12/23